Agency: Drug Enforcement Administration
Years: 20002001200220032004200520062007200820092010201120122013[FR Doc 02-32008] 1. Marion ``Molly'' Fry, M.D.; Revocation of Registration
On March 7, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Marion ``Molly'' Fry, M.D. (Dr. Fry), proposing to revoke her DEA Certificate of Registration, BM4859178, and deny any pending applications for registration as a practitioner under 21 U.S.C.
Published: 2002-12-20 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-32007] 2. Houba, Inc., Culver, IN; Notice of Administrative Hearing, Summary of
This Notice of Administrative Hearing, Summary of Comments and Objections, regarding the application of Houba, Inc. (Houba), for registration as an importer of the Schedule II controlled substances raw opium, opium poppy, and poppy straw concentrate is published pursuant to 21 CFR 1301.34(a). On September 6, 2001, notice was published in the
Published: 2002-12-20 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31898] 3. Controlled Substances: Established Initial Aggregate Production Quotas for
This notice establishes initial 2003 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Published: 2002-12-19 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31949] 4. Indace, Inc., c/o Seegott, Inc.; Malladi, Inc. Suspension of Shipments
On January 25, 2001, the thenAdministrator of the Drug Enforcement Administration (DEA) issued an Order to Suspend Shipment to Indace, Inc. c/o Seegott, Inc. (Indace) of Elgin, Illinois, notifying it that pursuant to 21 U.S.C. 971, DEA had ordered the suspension of a shipment of 3,000 kilograms of ephedrine hydrochloride, a listed chemical,
Published: 2002-12-19 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31210] 5. Xtreme Enterprises, Inc.: Denial of Request for Registration To Handle List I
I. Background
On December 15, 2000, Xtreme Enterprises, Inc., (Respondent) applied to be registered with the Drug Enforcement Administration (DEA) as a distributor of the list I chemical ephedrine. After an investigation by DEA investigators, on April 6, 2001, the Deputy Assistant Administrator, Office of Diversion Control, issued an Order to
Published: 2002-12-11 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31208] 6. Minakshi B. Deshmukh, M.D., Revocation of Registration, Denial of
On July 11, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Minakshi B. Deshmukh, M.D. (Dr. Deshmukh) of Midland, Michigan, notifying her of an opportunity to show cause as to why DEA should not revoke her DEA Certificate of Registration, BD4361692
Published: 2002-12-11 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31209] 7. K-Nine Detectives; Denial of Application
On July 16, 2001, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to KNine Detectives (Respondent), proposing to deny its application, executed on February 14, 2000, for DEA Certificate of Registration as a researcher. The application was submitted on behalf
Published: 2002-12-11 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31070] 8. Manufacturer of Controlled Substances Notice of Registration
By Notice dated March 27, 2002, and published in the Federal Register on April 10, 2002, (67 FR 17467), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of fentanyl (9801), a basic class of
Published: 2002-12-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31071] 9. Importer of Controlled Substances; Notice of Registration
By Notice dated October 5, 2001, and published in the Federal Register on October 17, 2001 (66 FR 52781), B.I. Chemicals, Inc., which has changed its name to Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an
Published: 2002-12-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31072] 10. Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 5, 2001, and published in the Federal Register on October 17, 2001, (66 FR 52780), B.I. Chemicals, Inc. which changed its name to Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk
Published: 2002-12-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-31073] 11. Notice of Application
Pursuant to Section 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on June 21, 2002, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made Application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Sufentanil (9740), a basic class of controlled
Published: 2002-12-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30877] 12. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Drug Enforcement Administration (DEA) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2002-12-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30878] 13. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Drug Enforcement Administration (DEA) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2002-12-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30257] 14. Horst G. Blume, M.D.; Revocation of Registration
On July 26, 2002, the Deputy Assistant Administrator, Office of Division Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause by certified mail to Horst G. Blume, M.D. (Dr. Blume), notifying him of an opportunity to show cause as to why the DEA should not revoke his DEA Certificate of Registration, AB4035146, pursuant
Published: 2002-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30255] 15. Christopher E. Castle, M.D., Revocation of Registration
On March 14, 2002, the Deputy Assistant Administrator, Office of [[Page 71197]]
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause, Immediate Suspension of Registration, to
Christopher E. Castle, M.D. (Dr. Castle) of Seymour, Tennessee,
notifying him of an opportunity to show cause as to why DEA should not
Published: 2002-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30256] 16. Joseph H. Talley, M.D.; Revocation of Registration
On January 28, 2002, the Administrator of the Drug Enforcement Administration (DEA), issued an Order to Show Cause and Notice of Immediate suspension of Registration to Joseph H. Talley, M.D. (Respondent) of Grover, North Carolina. The Respondent was notified of an opportunity to show cause as to why DEA should not revoke his DEA Certificate
Published: 2002-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30253] 17. Clark G. Triftshauser, M.D., Revocation of Registration
On May 13, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Clark G. Triftshauser, M.D. (Dr. Triftshauser) of Albion, New York, notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration,
Published: 2002-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30254] 18. Johnnie Melvin Turner, M.D.; Revocation of Registration
On June 18, 2001, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Johnnie Melvin Turner, M.D. (Dr. Turner) of Chicago Illinois, notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, BT5794866
Published: 2002-11-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30022] 19. James F. Graves, M.D.; Revocation of Registration
On April 8, 2002, the Administrator of the Drug Enforcement Administration (DEA), issued an Order to Show Cause, Immediate Suspension of Registration, to James F. Graves, M.D. (Dr. Graves) of Milton, Florida, notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, AG3101235 under 21
Published: 2002-11-27 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-30021] 20. K.V.M. Enterprises; Denial of Registration
On February 25, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to K.V.M. Enterprises (KVM) of Detroit, Michigan, notifying it of an opportunity to show cause as to why DEA should not deny its application for DEA registration as a distributor of list 1
Published: 2002-11-27 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-28737] 21. Agency Information Collection Activities: Proposed Collection; Comment
The Department of Justice (DOJ), Drug Enforcement Administration (DEA) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2002-11-13 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-28657] 22. Manufacturer of Controlled Substances; Notice of Registration
By Notice dated September 25, 2001, and published in the Federal Register on October 3, 2001 (66 FR 50453), Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed
Published: 2002-11-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-28661] 23. Lazaro Guerra, M.D.; Revocation of Registration
On February 25, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Lazaro Guerra, M.D. (Dr. Guerra) of Hialeah, Florida, notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, AG8202765 under
Published: 2002-11-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-28658] 24. Ramona K. Morris, M.D.; Revocation of Registration
On April 19, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Ramona K. Morris, M.D. (Dr. Morris) of Kingman, Kansas, notifying her of an opportunity to show cause as to why DEA should not revoke her DEA Certificate of Registration, BM6789056 under 21
Published: 2002-11-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 02-28656] 25. Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 11, 2002, and published in the Federal Register on April 26, 2002 (67 FR 20828), Noramco of Delaware, Inc., Division of McNeilab, Inc., which has changed its name to Noramco of Delaware, Inc., Division of OrthoMcNeil, Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal to the Drug
Published: 2002-11-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
Years: 20002001200220032004200520062007200820092010201120122013